Twitter
LinkedIn

Who We Are
Our Companies
Our News
Our Team

December 2020

Allogene Therapeutics (NASDAQ: ALLO)

Pioneer in allogeneic cell therapies for cancer

Allogene.com

Subscribe to the TPG Healthcare Newsletter

First*

Last*

Email*

Thank you!

Information provided above will be used by a third-party platform for distributing the newsletter. You can unsubscribe at any time via the link in the footer of the newsletter.

Explore TPG
Connect With Us
- media@tpg.com
- InvestorRelations@tpg.com
Limited Partner Login
Our Offices

Twitter
LinkedIn

© 2025 Tarrant Capital IP, LLC, All Rights Reserved.

Terms of Use | Phishing | Privacy & Cybersecurity | CCPA Privacy Statement | UK Disclosures